Published in J Cell Sci on March 16, 2010
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest (2013) 2.03
Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol (2013) 1.89
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol (2010) 1.89
EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol (2013) 1.77
Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol (2012) 1.66
Eph/ephrin molecules--a hub for signaling and endocytosis. Genes Dev (2010) 1.64
VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol (2012) 1.44
Eph receptors and ephrins: therapeutic opportunities. Annu Rev Pharmacol Toxicol (2014) 1.04
PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity. PLoS One (2011) 0.96
BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. Angiogenesis (2012) 0.95
Non-SH2/PDZ reverse signaling by ephrins. Semin Cell Dev Biol (2011) 0.90
Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy. J Histochem Cytochem (2012) 0.87
In vivo evolution of tumor-derived endothelial cells. PLoS One (2012) 0.86
Targeting the Eph System with Peptides and Peptide Conjugates. Curr Drug Targets (2015) 0.84
EphrinB1/EphB3b Coordinate Bidirectional Epithelial-Mesenchymal Interactions Controlling Liver Morphogenesis and Laterality. Dev Cell (2016) 0.83
Regulation of signaling interactions and receptor endocytosis in growing blood vessels. Cell Adh Migr (2014) 0.82
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization. Clin Cancer Res (2013) 0.81
EphrinB1 interacts with CNK1 and promotes cell migration through c-Jun N-terminal kinase (JNK) activation. J Biol Chem (2014) 0.81
The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts. J Biol Chem (2012) 0.80
Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival. Neuro Oncol (2013) 0.80
Skeletal anabolism, PTH, and the bone-vascular axis. J Bone Miner Res (2011) 0.79
EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells. Elife (2016) 0.78
Ephrin-Bs Drive Junctional Downregulation and Actin Stress Fiber Disassembly to Enable Wound Re-epithelialization. Cell Rep (2015) 0.77
Investigation of the interactions between the EphB2 receptor and SNEW peptide variants. Growth Factors (2014) 0.76
Behavioral improvement and regulation of molecules related to neuroplasticity in ischemic rat spinal cord treated with PEDF. Neural Plast (2014) 0.75
Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell (1998) 10.61
Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol (2003) 7.93
Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol (2005) 7.14
Coordination of Rho GTPase activities during cell protrusion. Nature (2009) 6.54
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol (2000) 4.80
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev (1999) 4.75
Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell (1999) 4.17
Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell (2006) 3.51
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev (2005) 3.29
PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron (1998) 3.09
Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell (2005) 2.88
Collective cell migration in morphogenesis and cancer. Int J Dev Biol (2004) 2.80
Crystal structure of an Eph receptor-ephrin complex. Nature (2002) 2.80
Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol (2003) 2.79
Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol (2001) 2.46
Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nat Neurosci (2000) 2.45
The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature (2001) 2.34
Retinal axon response to ephrin-as shows a graded, concentration-dependent transition from growth promotion to inhibition. Neuron (2004) 2.32
EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell (2002) 2.31
The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev (2004) 2.23
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem (2004) 2.17
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A (2004) 2.01
Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons. Neuron (1999) 1.97
Ephrin signaling in vivo: look both ways. Dev Dyn (2005) 1.93
Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci (2006) 1.86
Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development (2002) 1.84
EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron (1999) 1.81
The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif. J Biol Chem (1999) 1.66
EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. FASEB J (2002) 1.58
Paradoxes of the EphB4 receptor in cancer. Cancer Res (2007) 1.58
Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res (2005) 1.57
Eph receptor tyrosine kinases in angiogenesis: from development to disease. Angiogenesis (2004) 1.55
Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J (1999) 1.49
Cross-correlation analysis of inner-leaflet-anchored green fluorescent protein co-redistributed with IgE receptors and outer leaflet lipid raft components. Biophys J (2001) 1.41
Bifunctional action of ephrin-B1 as a repellent and attractant to control bidirectional branch extension in dorsal-ventral retinotopic mapping. Development (2003) 1.40
Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity. J Biol Chem (2006) 1.40
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood (2009) 1.38
Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J Cell Sci (2002) 1.36
Association of Dishevelled with Eph tyrosine kinase receptor and ephrin mediates cell repulsion. EMBO J (2003) 1.34
Serine phosphorylation of ephrinB2 regulates trafficking of synaptic AMPA receptors. Nat Neurosci (2008) 1.34
Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci (2003) 1.28
EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neurosci Res (2004) 1.19
Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J (2005) 1.18
Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. Genes Dev (2009) 1.17
The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. Int J Cancer (2010) 1.12
Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol Biol Cell (2002) 1.09
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res (1998) 1.06
Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem J (2009) 1.06
Co-operative Cdc42 and Rho signalling mediates ephrinB-triggered endothelial cell retraction. Biochem J (2007) 1.04
Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. J Cell Sci (2008) 1.00
Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation. J Biol Chem (2003) 0.99
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro. World J Gastroenterol (2005) 0.96
Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Dig Liver Dis (2007) 0.88
Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high-affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ-RGS3 protein. Eur J Biochem (2004) 0.85
Analysis of PDZ-RGS3 function in ephrin-B reverse signaling. Methods Enzymol (2004) 0.81
The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell (2009) 5.33
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature (2010) 4.85
Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell (2006) 3.51
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med (2013) 3.35
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev (2005) 3.29
Regulation of vascular morphogenesis by Notch signaling. Genes Dev (2007) 3.10
Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol (2003) 2.79
EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell (2010) 2.54
Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell (2012) 2.45
Hippocampal plasticity requires postsynaptic ephrinBs. Nat Neurosci (2003) 2.37
Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol (2010) 2.22
Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med (2007) 2.15
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature (2012) 2.13
Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat Protoc (2010) 2.12
Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell (2003) 2.11
DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood (2009) 2.07
The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell (2010) 2.01
Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol (2013) 1.89
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol (2010) 1.89
Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C. Nature (2004) 1.88
Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am J Hum Genet (2004) 1.78
Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res (2010) 1.70
Eph/ephrin molecules--a hub for signaling and endocytosis. Genes Dev (2010) 1.64
Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J Cell Biol (2004) 1.60
A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J (2013) 1.58
Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J Clin Invest (2010) 1.54
Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. Mol Cell Biol (2003) 1.54
Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res (2008) 1.43
A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1. Nat Genet (2004) 1.39
Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med (2011) 1.25
Lipid phosphate phosphatase 3 enables efficient thymic egress. J Exp Med (2011) 1.23
Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat Med (2012) 1.23
Notch controls retinal blood vessel maturation and quiescence. Development (2013) 1.20
Identification of a clonally expanding haematopoietic compartment in bone marrow. EMBO J (2012) 1.19
Molecular differentiation and specialization of vascular beds. Angiogenesis (2009) 1.16
Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves. Science (2007) 1.14
Microtubule remodelling is required for the front-rear polarity switch during contact inhibition of locomotion. J Cell Sci (2011) 1.14
Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res (2004) 1.13
Sox17 is indispensable for acquisition and maintenance of arterial identity. Nat Commun (2013) 1.12
alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res (2008) 1.11
ERK activation causes epilepsy by stimulating NMDA receptor activity. EMBO J (2007) 1.10
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin Cancer Res (2013) 1.06
Co-operative Cdc42 and Rho signalling mediates ephrinB-triggered endothelial cell retraction. Biochem J (2007) 1.04
A key role for Abl family kinases in EphA receptor-mediated growth cone collapse. Mol Cell Neurosci (2005) 1.03
Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium. J Comp Neurol (2007) 1.03
NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function. Angiogenesis (2013) 1.03
lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development (2012) 1.03
Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating β-oxidation-dependent mitochondrial ROS production. Cell Metab (2013) 1.02
Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction. Genes Dev (2009) 1.01
Peripheral mural cell recruitment requires cell-autonomous heparan sulfate. Blood (2009) 1.00
Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17. Circ Res (2012) 0.99
Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells. Mol Cell Neurosci (2003) 0.98
Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis. Development (2014) 0.97
Fbxw7 controls angiogenesis by regulating endothelial Notch activity. PLoS One (2012) 0.97
Evaluation of TRAP-sequencing technology with a versatile conditional mouse model. Nucleic Acids Res (2013) 0.97
G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev Cell (2013) 0.97
Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice. J Clin Invest (2012) 0.96
Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. J Clin Invest (2013) 0.94
Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization. Circ Res (2006) 0.90
The Junctional Adhesion Molecule-B regulates JAM-C-dependent melanoma cell metastasis. FEBS Lett (2012) 0.90
Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling. Mol Biol Cell (2013) 0.90
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy. J Clin Invest (2014) 0.90
Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation (2013) 0.88
EphB-ephrin-B2 interactions are required for thymus migration during organogenesis. Proc Natl Acad Sci U S A (2010) 0.86
JAM-B regulates maintenance of hematopoietic stem cells in the bone marrow. Blood (2011) 0.86
Ena/VASP proteins mediate repulsion from ephrin ligands. J Cell Sci (2006) 0.85
DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular. Clin Sci (Lond) (2012) 0.84
Ephrin-B2 controls PDGFRβ internalization and signaling. Genes Dev (2013) 0.84
Regulation of signaling interactions and receptor endocytosis in growing blood vessels. Cell Adh Migr (2014) 0.82
S6K1 controls pancreatic β cell size independently of intrauterine growth restriction. J Clin Invest (2015) 0.81
Müller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid. J Exp Med (2014) 0.80
Lymphatic endothelial differentiation: start out with Sox--carry on with Prox. Genome Biol (2008) 0.80
Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo. Development (2014) 0.80
Master and commander: continued expression of Prox1 prevents the dedifferentiation of lymphatic endothelial cells. Genes Dev (2008) 0.79
Turning on the angiogenic microswitch. Nat Med (2010) 0.79
Junctional adhesion molecule (JAM)-C deficient C57BL/6 mice develop a severe hydrocephalus. PLoS One (2012) 0.78
Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells. Stem Cells (2014) 0.78
Development. Aorta's cardinal secret. Science (2009) 0.77
Corrigendum: Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature (2016) 0.75
Nerve cell signposts in the blood vessel roadmap. Circ Res (2006) 0.75
Laminar flow downregulates Notch activity to promote lymphatic sprouting. J Clin Invest (2017) 0.75
Corrigendum: Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature (2016) 0.75
Corrigendum: Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. Nat Commun (2017) 0.75